CClinicalTrials.gg
RecruitingNCT06523790EXMET-BW&YUpdated Jul 26, 2024

The Impact of Exercise Methods on Human Body Functions and Metabolism

An interventional study of Yoga and Brisk walking in Metabolic Syndrome, sponsored by Zhoukou Normal University. Recruiting at 1 site in China. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-26.

Sponsored by Zhoukou Normal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled Jan 2024, registered Jul 2024).
  • Started Jan 2024; still recruiting 2 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The objective of this study is to compare the effects of 8 months of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women. Participants will be randomly assigned to either a yoga group or a walking group. The yoga group will undergo 90-minute sessions, 3 times per week, while the walking group will engage in one-hour sessions, 6 times per week. Physical and metabolic markers will be measured at baseline and after 8 months of intervention.

Read the detailed description

This randomized controlled trial aims to investigate the differential impacts of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women over an 8-month period. The study will recruit women aged 18-65 years, who will be randomly assigned to either a yoga group or a walking group.

Yoga Group: Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week.

Walking Group: Participants in the walking group will engage in one-hour fast-paced walking sessions, 6 times per week.

Outcome Measures: Physical and metabolic markers will be assessed at baseline and after 8 months of exercise intervention. The primary outcomes will include changes in body weight, BMI, visceral fat, and basal metabolism. Metabolic biomarkers such as serum leptin, glucose, total cholesterol (TC), apolipoprotein A (APOA), and apolipoprotein B (APOB) will also be measured.

Participants will be monitored for adherence to the exercise protocol and any adverse events throughout the study. Data will be collected during the intervention, and analyzed to determine the differential effects of yoga and walking on the measured outcomes.

The study aims to provide insights into the relative benefits of yoga and walking exercise regimens on women's health, particularly in terms of body composition and metabolic health, thereby informing future exercise recommendations and health interventions.

02

Conditions studied

  • Metabolic Syndrome

Browse trials for

Keywords

  • Yoga, Walking, Exercise, Body Composition, Metabolic Health
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.

This study's planned enrollment of 84 is above the median of 60 across 1,460 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

This is the only study on the registry with Zhoukou Normal University as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

Female participants aged 18-65 years; Willing and able to participate in an 8-month exercise program; Generally healthy with no contraindications to physical activity; Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

Current participation in a structured exercise program; Known cardiovascular, respiratory, or metabolic disorders that contraindicate exercise; Pregnancy or planning to become pregnant during the study period; Use of medications affecting metabolism or physical activity levels; Any other condition that, in the opinion of the investigators, would make participation unsafe or not feasible

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Yoga Group

    Participants in this group will undergo 90-minute yoga sessions, 3 times per week, for 8 months. The yoga intervention includes a combination of asanas (postures), pranayama (breathing exercises), and meditation designed to improve flexibility, strength, and mental well-being.

    Behavioral: Yoga

  • Experimental
    Walking Group

    Participants in this group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking intervention is designed to improve cardiovascular fitness, endurance, and support weight loss.

    Behavioral: Brisk walking

Interventions

  • BehavioralYoga

    Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week, for 8 months. The sessions will include a combination of asanas (postures), pranayama (breathing exercises), and meditation.

  • BehavioralBrisk walking

    Participants in the brisk walking group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking regimen is designed to improve cardiovascular fitness, endurance, and support weight loss.

06

What researchers measure

Primary outcomes

  1. Change in Body Weight

    Measurement of body weight changes in kilograms from baseline to 8 months.

    Time frame: Baseline, 8 months

  2. Change in Body Mass Index (BMI)

    Measurement of BMI changes calculated as weight in kilograms divided by height in meters squared from baseline to 8 months.

    Time frame: Baseline, 8 months

Secondary outcomes

  1. Change in Serum Leptin Levels

    Measurement of serum leptin levels in ng/mL from baseline to 8 months.

    Time frame: Baseline, 8 months

  2. Change in Fasting Blood Glucose Levels

    Measurement of fasting blood glucose levels in mg/dL from baseline to 8 months.

    Time frame: Baseline, 8 months

  3. Change in Total Cholesterol (TC) Levels

    Measurement of total cholesterol levels in mg/dL from baseline to 8 months.

    Time frame: Baseline, 8 months

07

Study locations

1 of 1 sites recruiting
  • Zhou Kou Normal University
    Zhoukou, Henan, China
    • Jin Li · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — The data will not be shared due to concerns about participant privacy and the sensitivity of the health data collected.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06523790
Lead sponsor
Zhoukou Normal University
Responsible party
Jin Li (instructor, Zhoukou Normal University) — Principal investigator
First posted
Jul 26, 2024
Start date
Jan 3, 2024
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jul 26, 2024

Study contacts

jin li
Contact
lijin0213@126.com
(86)18438175639
xiaomeng liu
principal investigator · Zhoukou Normal University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion